SRGN and breast cancer: Although the extent to which serglycin contributes to mechanotransduction remains understudied, a recent study reported that upregulation of serglycin expression in chemoresistant breast cancer cells activates FAK signaling (128), indicating a potential connection between serglycin and mechanotransduction (129).